Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (111-120 of 326) with videos related to

Pageof 33
Sort By:
Journal of Clinical Medicine|November 13, 2021
Efficacy of a Preparation Based on Calcium Butyrate, <i>Bifidobacterium bifidum</i>, <i>Bifidobacterium lactis</i>, and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis: A Prospective Observational StudyGian Paolo Caviglia, Federico De Blasio, Marta Vernero, et al.
Nursing Reports (Pavia, Italy)|December 30, 2021
Inflammatory Bowel Disease Nurse-Practical MessagesChiara Rosso, Alami Aroussi Aaron, Angelo Armandi, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2025
Liver fibrosis is associated with clinical and economic burden of cardiovascular disease in MASHKathleen Corey, Anurag Mehta, Kamal Kant Mangla, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 25, 2017
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling studySalvatore Petta, Mohammed Eslam, Luca Valenti, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeGiulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 3, 2023
A nutrigenetic precision approach for the management of non-alcoholic fatty liver diseaseNuria Perez-Diaz-Del-Campo, Eleonora Dileo, Gabriele Castelnuovo, et al.
Journal of Hepatology|December 15, 2010
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposityAnna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, et al.
World Journal of Gastroenterology|October 1, 2016
Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014Giorgio Maria Saracco, Andrea Evangelista, Sharmila Fagoonee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individualsChiara Saponaro, Silvia Sabatini, Melania Gaggini, et al.
Pageof 33

Showing results (111-120 of 326) with videos related to

Sort By:
Pageof 33
Journal of Clinical Medicine|November 13, 2021
Efficacy of a Preparation Based on Calcium Butyrate, <i>Bifidobacterium bifidum</i>, <i>Bifidobacterium lactis</i>, and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis: A Prospective Observational StudyGian Paolo Caviglia, Federico De Blasio, Marta Vernero, et al.
Nursing Reports (Pavia, Italy)|December 30, 2021
Inflammatory Bowel Disease Nurse-Practical MessagesChiara Rosso, Alami Aroussi Aaron, Angelo Armandi, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2025
Liver fibrosis is associated with clinical and economic burden of cardiovascular disease in MASHKathleen Corey, Anurag Mehta, Kamal Kant Mangla, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 25, 2017
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling studySalvatore Petta, Mohammed Eslam, Luca Valenti, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeGiulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 3, 2023
A nutrigenetic precision approach for the management of non-alcoholic fatty liver diseaseNuria Perez-Diaz-Del-Campo, Eleonora Dileo, Gabriele Castelnuovo, et al.
Journal of Hepatology|December 15, 2010
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposityAnna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, et al.
World Journal of Gastroenterology|October 1, 2016
Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014Giorgio Maria Saracco, Andrea Evangelista, Sharmila Fagoonee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individualsChiara Saponaro, Silvia Sabatini, Melania Gaggini, et al.
Pageof 33